Skip to main content
Top
Published in: Gut Pathogens 1/2017

Open Access 01-12-2017 | Research

The in vitro and ex vivo effect of Auranta 3001 in preventing Cryptosporidium hominis and Cryptosporidium parvum infection

Authors: Alexandros Ch Stratakos, Filip Sima, Patrick Ward, Mark Linton, Carmel Kelly, Laurette Pinkerton, Lavinia Stef, Ioan Pet, Tiberiu Iancu, Gratiela Pircalabioru, Nicolae Corcionivoschi

Published in: Gut Pathogens | Issue 1/2017

Login to get access

Abstract

Background

Cryptosporidium is a major cause of diarrhea worldwide in both humans and farm animals with no completely effective treatment available at present. In this study, we assessed the inhibitory effect of different concentrations of Auranta 3001 (0.1, 0.5 and 1%), a novel natural feed supplement, on C. hominis and C. parvum invasion of human ileocecal adenocarcinoma (HCT-8), bovine primary cells and C. parvum invasion of HCT-8, bovine primary cells and bovine intestinal biopsies. The effect of the feed supplement on the production of pro-inflammatory cytokines IL-8 and INF-γ, the anti-inflammatory cytokine IL-10, the expression of CpSUB1 protease gene during infection was also assessed by quantitative PCR (q-PCR). Transepithelial electrical resistance (TEER) was employed to measure the integrity of tight junction dynamics of the culture models.

Results

Pre-treatment of intestinal cells or oocysts with the Auranta 3001 significantly reduced the invasiveness of C. hominis and C. parvum against HCT-8 and bovine primary cells in a dose dependent manner. The most pronounced reduction in the invasiveness of both parasites was observed when Auranta 3001 was present during infection. Levels of IL-8 were significantly reduced in both HCT-8 and bovine primary cells, while the levels of INF-γ and IL-10 showed opposite trends in the two cell lines during infection in the presence of Auranta 3001. CpSUB1 gene protease expression, which mediates infection, was significantly reduced suggesting that this enzyme is a possible target of Auranta 3001.

Conclusions

Although, C. hominis and C. parvum use different invasion mechanisms to infect cells, the novel feed additive can significantly attenuate the entry of Cryptosporidium in HCT-8 cells, primary bovine cells and bovine intestinal biopsies and thus provide an alternative method to control cryptosporidiosis.
Literature
1.
go back to reference Checkley W, White AC Jr, Jaganath D, Arrowood MJ, Chalmers RM, Chen XM, Fayer R, Griffiths JK, Guerrant RL, Hedstrom L, et al. A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for Cryptosporidium. Lancet Infect Dis. 2015;15(1):85–94.CrossRefPubMed Checkley W, White AC Jr, Jaganath D, Arrowood MJ, Chalmers RM, Chen XM, Fayer R, Griffiths JK, Guerrant RL, Hedstrom L, et al. A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for Cryptosporidium. Lancet Infect Dis. 2015;15(1):85–94.CrossRefPubMed
4.
go back to reference Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide. J Infect Dis. 2001;184(1):103–6.CrossRefPubMed Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide. J Infect Dis. 2001;184(1):103–6.CrossRefPubMed
5.
go back to reference Huang DB, Chappell C, Okhuysen PC. Cryptosporidiosis in children. Semin Pediatr Infect Dis. 2004;15(4):253–9.CrossRefPubMed Huang DB, Chappell C, Okhuysen PC. Cryptosporidiosis in children. Semin Pediatr Infect Dis. 2004;15(4):253–9.CrossRefPubMed
6.
go back to reference Fournet N, Deege MP, Urbanus AT, Nichols G, Rosner BM, Chalmers RM, Gorton R, Pollock KG, van der Giessen JW, Wever PC, et al. Simultaneous increase of Cryptosporidium infections in the Netherlands, the United Kingdom and Germany in late summer season, 2012. Euro Surveill. 2013;18(2):20348.PubMed Fournet N, Deege MP, Urbanus AT, Nichols G, Rosner BM, Chalmers RM, Gorton R, Pollock KG, van der Giessen JW, Wever PC, et al. Simultaneous increase of Cryptosporidium infections in the Netherlands, the United Kingdom and Germany in late summer season, 2012. Euro Surveill. 2013;18(2):20348.PubMed
7.
go back to reference Striepen B. Parasitic infections: time to tackle cryptosporidiosis. Nature. 2013;503(7475):189–91.CrossRefPubMed Striepen B. Parasitic infections: time to tackle cryptosporidiosis. Nature. 2013;503(7475):189–91.CrossRefPubMed
8.
go back to reference Imboden M, Riggs MW, Schaefer DA, Homan EJ, Bremel RD. Antibodies fused to innate immune molecules reduce initiation of Cryptosporidium parvum infection in mice. Antimicrob Agents Chemother. 2010;54(4):1385–92.CrossRefPubMedPubMedCentral Imboden M, Riggs MW, Schaefer DA, Homan EJ, Bremel RD. Antibodies fused to innate immune molecules reduce initiation of Cryptosporidium parvum infection in mice. Antimicrob Agents Chemother. 2010;54(4):1385–92.CrossRefPubMedPubMedCentral
9.
go back to reference Castellanos-Gonzalez A, White AC Jr, Ojo KK, Vidadala RS, Zhang Z, Reid MC, Fox AM, Keyloun KR, Rivas K, Irani A, et al. A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis. J Infect Dis. 2013;208(8):1342–8.CrossRefPubMedPubMedCentral Castellanos-Gonzalez A, White AC Jr, Ojo KK, Vidadala RS, Zhang Z, Reid MC, Fox AM, Keyloun KR, Rivas K, Irani A, et al. A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis. J Infect Dis. 2013;208(8):1342–8.CrossRefPubMedPubMedCentral
10.
go back to reference Gaafar MR. Efficacy of Allium sativum [garlic] against experimental cryptosporidiosis. Alex J Med. 2012;48:59–66.CrossRef Gaafar MR. Efficacy of Allium sativum [garlic] against experimental cryptosporidiosis. Alex J Med. 2012;48:59–66.CrossRef
11.
go back to reference Cabada MM, White AC Jr. Treatment of cryptosporidiosis: do we know what we think we know? Curr Opin Infect Dis. 2010;23(5):494–9.CrossRefPubMed Cabada MM, White AC Jr. Treatment of cryptosporidiosis: do we know what we think we know? Curr Opin Infect Dis. 2010;23(5):494–9.CrossRefPubMed
12.
go back to reference De Waele V, Speybroeck N, Berkvens D, Mulcahy G, Murphy TM. Control of cryptosporidiosis in neonatal calves: use of halofuginone lactate in two different calf rearing systems. Prevent Vet Med. 2010;96(3–4):143–51.CrossRef De Waele V, Speybroeck N, Berkvens D, Mulcahy G, Murphy TM. Control of cryptosporidiosis in neonatal calves: use of halofuginone lactate in two different calf rearing systems. Prevent Vet Med. 2010;96(3–4):143–51.CrossRef
13.
go back to reference Silverlas C, Bjorkman C, Egenvall A. Systematic review and meta-analyses of the effects of halofuginone against calf cryptosporidiosis. Prevent Vet Med. 2009;91(2–4):73–84.CrossRef Silverlas C, Bjorkman C, Egenvall A. Systematic review and meta-analyses of the effects of halofuginone against calf cryptosporidiosis. Prevent Vet Med. 2009;91(2–4):73–84.CrossRef
14.
go back to reference Teichmann K, Kuliberda M, Schatzmayr G, Pacher T, Zitterl-Eglseer K, Joachim A, Hadacek F. In vitro inhibitory effects of plant-derived by-products against Cryptosporidium parvum. Parasite. 2016;23:41.CrossRefPubMedPubMedCentral Teichmann K, Kuliberda M, Schatzmayr G, Pacher T, Zitterl-Eglseer K, Joachim A, Hadacek F. In vitro inhibitory effects of plant-derived by-products against Cryptosporidium parvum. Parasite. 2016;23:41.CrossRefPubMedPubMedCentral
15.
go back to reference Shahiduzzaman M, Dyachenko V, Khalafalla RE, Desouky AY, Daugschies A. Effects of curcumin on Cryptosporidium parvum in vitro. Parasitol Res. 2009;105(4):1155–61.CrossRefPubMed Shahiduzzaman M, Dyachenko V, Khalafalla RE, Desouky AY, Daugschies A. Effects of curcumin on Cryptosporidium parvum in vitro. Parasitol Res. 2009;105(4):1155–61.CrossRefPubMed
16.
go back to reference Wanyiri JW, Techasintana P, O’Connor RM, Blackman MJ, Kim K, Ward HD. Role of CpSUB1, a subtilisin-like protease, in Cryptosporidium parvum infection in vitro. Eukaryot Cell. 2009;8(4):470–7.CrossRefPubMedPubMedCentral Wanyiri JW, Techasintana P, O’Connor RM, Blackman MJ, Kim K, Ward HD. Role of CpSUB1, a subtilisin-like protease, in Cryptosporidium parvum infection in vitro. Eukaryot Cell. 2009;8(4):470–7.CrossRefPubMedPubMedCentral
17.
go back to reference Hashim A, Clyne M, Mulcahy G, Akiyoshi D, Chalmers R, Bourke B. Host cell tropism underlies species restriction of human and bovine Cryptosporidium parvum genotypes. Infect Immun. 2004;72(10):6125–31.CrossRefPubMedPubMedCentral Hashim A, Clyne M, Mulcahy G, Akiyoshi D, Chalmers R, Bourke B. Host cell tropism underlies species restriction of human and bovine Cryptosporidium parvum genotypes. Infect Immun. 2004;72(10):6125–31.CrossRefPubMedPubMedCentral
19.
go back to reference O’Grady NP, Preas HL, Pugin J, Fiuza C, Tropea M, Reda D, Banks SM, Suffredini AF. Local inflammatory responses following bronchial endotoxin instillation in humans. Am J Respir Crit Care Med. 2001;163(7):1591–8.CrossRefPubMed O’Grady NP, Preas HL, Pugin J, Fiuza C, Tropea M, Reda D, Banks SM, Suffredini AF. Local inflammatory responses following bronchial endotoxin instillation in humans. Am J Respir Crit Care Med. 2001;163(7):1591–8.CrossRefPubMed
20.
go back to reference Weyl-Feinstein S, Markovics A, Eitam H, Orlov A, Yishay M, Agmon R, Miron J, Izhaki I, Shabtay A. Short communication: effect of pomegranate-residue supplement on Cryptosporidium parvum oocyst shedding in neonatal calves. J Dairy Sci. 2014;97(9):5800–5.CrossRefPubMed Weyl-Feinstein S, Markovics A, Eitam H, Orlov A, Yishay M, Agmon R, Miron J, Izhaki I, Shabtay A. Short communication: effect of pomegranate-residue supplement on Cryptosporidium parvum oocyst shedding in neonatal calves. J Dairy Sci. 2014;97(9):5800–5.CrossRefPubMed
21.
go back to reference Pantenburg B, Dann SM, Wang HC, Robinson P, Castellanos-Gonzalez A, Lewis DE, White AC Jr. Intestinal immune response to human Cryptosporidium sp. infection. Infect Immun. 2008;76(1):23–9.CrossRefPubMed Pantenburg B, Dann SM, Wang HC, Robinson P, Castellanos-Gonzalez A, Lewis DE, White AC Jr. Intestinal immune response to human Cryptosporidium sp. infection. Infect Immun. 2008;76(1):23–9.CrossRefPubMed
22.
go back to reference Lacroix S, Mancassola R, Naciri M, Laurent F. Cryptosporidium parvum-specific mucosal immune response in C57BL/6 neonatal and gamma interferon-deficient mice: role of tumor necrosis factor alpha in protection. Infect Immun. 2001;69(3):1635–42.CrossRefPubMedPubMedCentral Lacroix S, Mancassola R, Naciri M, Laurent F. Cryptosporidium parvum-specific mucosal immune response in C57BL/6 neonatal and gamma interferon-deficient mice: role of tumor necrosis factor alpha in protection. Infect Immun. 2001;69(3):1635–42.CrossRefPubMedPubMedCentral
23.
go back to reference Matsui M, Roche L, Soupe-Gilbert ME, Hasan M, Monchy D, Goarant C. High level of IL-10 expression in the blood of animal models possibly relates to resistance against leptospirosis. Cytokine. 2017;96:144–51.CrossRefPubMed Matsui M, Roche L, Soupe-Gilbert ME, Hasan M, Monchy D, Goarant C. High level of IL-10 expression in the blood of animal models possibly relates to resistance against leptospirosis. Cytokine. 2017;96:144–51.CrossRefPubMed
24.
go back to reference Carruthers VB, Blackman MJ. A new release on life: emerging concepts in proteolysis and parasite invasion. Mol Microbiol. 2005;55(6):1617–30.CrossRefPubMed Carruthers VB, Blackman MJ. A new release on life: emerging concepts in proteolysis and parasite invasion. Mol Microbiol. 2005;55(6):1617–30.CrossRefPubMed
26.
go back to reference Forney JR, Yang S, Du C, Healey MC. Efficacy of serine protease inhibitors against Cryptosporidium parvum infection in a bovine fallopian tube epithelial cell culture system. J Parasitol. 1996;82(4):638–40.CrossRefPubMed Forney JR, Yang S, Du C, Healey MC. Efficacy of serine protease inhibitors against Cryptosporidium parvum infection in a bovine fallopian tube epithelial cell culture system. J Parasitol. 1996;82(4):638–40.CrossRefPubMed
27.
go back to reference Wanyiri JW, O’Connor R, Allison G, Kim K, Kane A, Qiu J, Plaut AG, Ward HD. Proteolytic processing of the Cryptosporidium glycoprotein gp40/15 by human furin and by a parasite-derived furin-like protease activity. Infect Immun. 2007;75(1):184–92.CrossRefPubMed Wanyiri JW, O’Connor R, Allison G, Kim K, Kane A, Qiu J, Plaut AG, Ward HD. Proteolytic processing of the Cryptosporidium glycoprotein gp40/15 by human furin and by a parasite-derived furin-like protease activity. Infect Immun. 2007;75(1):184–92.CrossRefPubMed
28.
go back to reference Feng X, Akiyoshi DE, Widmer G, Tzipori S. Characterization of subtilase protease in Cryptosporidium parvum and C. hominis. J Parasitol. 2007;93(3):619–26.CrossRefPubMed Feng X, Akiyoshi DE, Widmer G, Tzipori S. Characterization of subtilase protease in Cryptosporidium parvum and C. hominis. J Parasitol. 2007;93(3):619–26.CrossRefPubMed
29.
go back to reference Wanyiri J, Ward H. Molecular basis of Cryptosporidium-host cell interactions: recent advances and future prospects. Future Microbiol. 2006;1(2):201–8.CrossRefPubMed Wanyiri J, Ward H. Molecular basis of Cryptosporidium-host cell interactions: recent advances and future prospects. Future Microbiol. 2006;1(2):201–8.CrossRefPubMed
30.
go back to reference Chen ML, Pothoulakis C, LaMont JT. Protein kinase C signaling regulates ZO-1 translocation and increased paracellular flux of T84 colonocytes exposed to Clostridium difficile toxin A. J Biol Chem. 2002;277(6):4247–54.CrossRefPubMed Chen ML, Pothoulakis C, LaMont JT. Protein kinase C signaling regulates ZO-1 translocation and increased paracellular flux of T84 colonocytes exposed to Clostridium difficile toxin A. J Biol Chem. 2002;277(6):4247–54.CrossRefPubMed
31.
go back to reference Srinivasan B, Kolli AR, Esch MB, Abaci HE, Shuler ML, Hickman JJ. TEER measurement techniques for in vitro barrier model systems. J Lab Autom. 2015;20(2):107–26.CrossRefPubMedPubMedCentral Srinivasan B, Kolli AR, Esch MB, Abaci HE, Shuler ML, Hickman JJ. TEER measurement techniques for in vitro barrier model systems. J Lab Autom. 2015;20(2):107–26.CrossRefPubMedPubMedCentral
32.
go back to reference Gookin JL, Nordone SK, Argenzio RA. Host responses to Cryptosporidium infection. J Vet Intern Med. 2002;16(1):12–21.CrossRefPubMed Gookin JL, Nordone SK, Argenzio RA. Host responses to Cryptosporidium infection. J Vet Intern Med. 2002;16(1):12–21.CrossRefPubMed
34.
go back to reference Rosson D, O’Brien TG, Kampherstein JA, Szallasi Z, Bogi K, Blumberg PM, Mullin JM. Protein kinase C-alpha activity modulates transepithelial permeability and cell junctions in the LLC-PK1 epithelial cell line. J Biol Chem. 1997;272(23):14950–3.CrossRefPubMed Rosson D, O’Brien TG, Kampherstein JA, Szallasi Z, Bogi K, Blumberg PM, Mullin JM. Protein kinase C-alpha activity modulates transepithelial permeability and cell junctions in the LLC-PK1 epithelial cell line. J Biol Chem. 1997;272(23):14950–3.CrossRefPubMed
Metadata
Title
The in vitro and ex vivo effect of Auranta 3001 in preventing Cryptosporidium hominis and Cryptosporidium parvum infection
Authors
Alexandros Ch Stratakos
Filip Sima
Patrick Ward
Mark Linton
Carmel Kelly
Laurette Pinkerton
Lavinia Stef
Ioan Pet
Tiberiu Iancu
Gratiela Pircalabioru
Nicolae Corcionivoschi
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Gut Pathogens / Issue 1/2017
Electronic ISSN: 1757-4749
DOI
https://doi.org/10.1186/s13099-017-0192-y

Other articles of this Issue 1/2017

Gut Pathogens 1/2017 Go to the issue